Suppr超能文献

经皮腔内肾血管成形术及支架植入术治疗伴急性肾损伤需血液透析的严重动脉粥样硬化性肾动脉狭窄

[TREATMENT OF SEVERE ATHEROSCLEROTIC RENAL ARTERY STENOSIS WITH ACUTE KIDNEY INJURY REQUIRING HEMODIALYSIS BY PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY AND STENT IMPLANTATION].

作者信息

Abu-Amer Nabil, Beckerman Pazit

机构信息

Institute of Nephrology and Hypertension, Sheba Medical Center, Israel.

Sackler Faculty of Medicine, Tel Aviv University, Israel.

出版信息

Harefuah. 2021 Apr;160(4):210-214.

Abstract

Treatment of atherosclerotic renal artery stenosis (RAS) is still controversial. Several randomized controlled trials have shown that percutaneous transluminal renal angioplasty with stenting (PTRAS) is not superior to medical treatment, and the procedure is commonly reserved for malignant hypertension, flash pulmonary edema or deterioration of kidney function. The most challenging symptomatic RAS cases are patients with severe stenosis resulting in acute kidney injury (AKI) requiring acute hemodialysis. The risk-benefit ratio in these cases is uncertain. While those patients might benefit the most from revascularization, the success rate after prolonged time on dialysis is unknown. This is a representative case study of a patient with solitary kidney and high grade RAS who presented with anuric AKI indicated for hemodialysis. Twenty-eight days after starting hemodialysis the patient underwent PTRAS as a rescue therapy and 5 days after the procedure urine output resumed, the patient became polyuric and kidney function improved and the patient stopped hemodialysis.

摘要

动脉粥样硬化性肾动脉狭窄(RAS)的治疗仍存在争议。多项随机对照试验表明,经皮腔内肾血管成形术加支架置入术(PTRAS)并不优于药物治疗,该手术通常适用于恶性高血压、急性肺水肿或肾功能恶化。最具挑战性的有症状RAS病例是严重狭窄导致急性肾损伤(AKI)需要急性血液透析的患者。这些病例的风险效益比尚不确定。虽然这些患者可能从血运重建中获益最大,但长期透析后的成功率尚不清楚。这是一例有代表性的病例研究,患者为单肾且患有高级别RAS,出现无尿性AKI,需进行血液透析。开始血液透析28天后,患者接受PTRAS作为挽救治疗,术后5天尿量恢复,患者出现多尿,肾功能改善,停止血液透析。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验